Terra Innovatum to Participate in Canaccord Genuity’s 46th Annual Growth Conference
Rhea-AI Summary
Terra Innovatum (NASDAQ:NKLR) will participate in Canaccord Genuity’s 46th Annual Growth Conference, held August 11–13, 2026 at the InterContinental Boston. Chief Strategy Officer and SOLO Safeguards Director Massimo Morichi will deliver a live presentation and Q&A on Wednesday, August 12, 2026 at 9:30 a.m. ET in the Rose Kennedy II room.
The session will be webcast live via a dedicated link and the Terra Innovatum investor relations site. Management will also conduct one-on-one meetings with institutional investors and attend the conference’s Taste of Boston event. According to Terra Innovatum, management plans to discuss its commercial strategy, technology platform, and progress toward deployment of the SOLO Micro-Modular Reactor (SMR), aimed at providing scalable, CO2-free nuclear power for diverse applications.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 05 | Index inclusion | Positive | -7.3% | Added to Solactive nuclear components index tracked by Global X Uranium ETF |
| Jul 23 | NRC readiness review | Positive | +1.5% | Initiated voluntary NRC review supporting planned construction permit application |
| Jul 23 | Board appointment | Neutral | +1.5% | Terra board member appointed independent chairman of Approov |
| Jul 20 | Commercial deployment LOI | Positive | +12.0% | Waiken selected SOLO platform for up to 8 MWe capacity |
| Jul 20 | Commercial deployment LOI | Positive | +12.0% | Initial deployment planned for DIRECTV and SKY Brasil data centers |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
NKLR aligned with commercial and regulatory updates but diverged on index inclusion, with recorded reactions ranging from -7.25% to 11.98%.
Key Terms
micro-modular nuclear reactors technical
leu+ technical
haleu technical
behind-the-meter technical
radioisotopes medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company to conduct one-on-one investor meetings and participate in a fireside chat to be webcast live on Wednesday, August 12, 2026
Management to discuss the Company’s commercial strategy, technology platform and progress toward SOLO™ deployment
NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. ("Terra Innovatum" or the “Company”) (NASDAQ: NKLR), a developer of micro-modular nuclear reactors, today announced that members of its management team will participate in Canaccord Genuity’s 46th Annual Growth Conference, taking place August 11-13, 2026, at the InterContinental Boston, 510 Atlantic Avenue, Boston, Massachusetts.
Massimo Morichi, Terra Innovatum’s Chief Strategy Officer and SOLO™ Safeguards Director will host a live presentation and Q&A session at 9:30 a.m. ET on Wednesday, August 12 in the Rose Kennedy II room. A simultaneous webcast can be accessed via this link https://event.summitcast.com/view/WuFmFdTcA9mVsUGHZJFU62/guest_book?session_id=nBGYbDDbvYyKWVwwzG2Dws or alternatively the Terra Innovatum Investor Relations webpage.
Terra Innovatum will also host meetings with institutional investors throughout the conference. Conference attendees who would like to schedule a one-on-one meeting with Terra Innovatum’s management team may contact Investor Relations at Investors@terrainnovatum.com. In addition, the Terra Innovatum team will attend Canaccord Genuity’s Taste of Boston event on Tuesday evening, August 11.
Massimo Morichi, Founding Parter, Chief Strategy Officer, and SOLO™ Safeguards Director of Terra Innovatum, stated, “Canaccord Genuity’s Growth Conference has long been an important forum for bringing together innovative growth companies and the institutional investment community. We look forward to sharing Terra Innovatum’s strategy, the progress we are making with SOLO™, and our vision to make reliable, scalable nuclear power more accessible.”
ABOUT TERRA INNOVATUM & SOLO™
Terra Innovatum's mission is to make nuclear power accessible. We deliver simple and safe micro-reactor solutions that are scalable, affordable and deployable anywhere 1 MWe at a time. Terra Innovatum is a pioneering force in the energy sector, dedicated to delivering innovative and sustainable power solutions. Terra Innovatum plans to leverage cutting-edge nuclear technology through the SOLO™ Micro-Modular Reactor (SMR™) to provide efficient, safe, and environmentally conscious energy. With a mission to address global energy shortages, Terra Innovatum combines extensive expertise in nuclear industry design, manufacturing, and installation licensing to offer disruptive energy solutions. Committed to propelling technological advancements, Terra Innovatum and SOLO™ are dedicated to fostering prosperity and sustainability for humankind.
It is anticipated that SOLO™ will be available globally within the next three years. Conceptualized in 2018 and engineered over six years by experts in nuclear safety, licensing, innovation, and R&D, SOLO™ addresses pressing global energy demands with a market-ready solution. Built from readily available commercial off-the-shelf components, the proven licensing path for SOLO™ enables rapid deployment and minimizes supply chain risks, ensuring final cost predictability. Designed to adapt with evolving fuel options, SOLO™ supports both LEU+ and HALEU, offering a platform ready to transition to future fuel supplies.
SOLO™ will offer a wide range of versatile applications, providing CO2-free, behind-the-meter, and off-grid power solutions for data centers, mini-grids serving remote towns and villages, and large-scale industrial operations in hard-to-abate sectors like cement production, oil and gas, steel manufacturing, and mining. It also has the ability to supply heat for industrial applications and other specialized processes, including water treatment, desalination and co-generation. Thanks to its modular design, SOLO™ can easily scale to deliver up to 1GW or more of CO2-free power with a minimal footprint, making it an ideal solution for rapidly replacing fossil fuel-based thermal plants. Beyond electricity and heat generation, SOLO™ can also contribute to critical applications in the medical sector by producing radioisotopes essential for oncology research and cancer treatment.
To learn more, visit: investors.terrainnovatum.com.
Follow us on X: x.com/TerraInnovatum and
LinkedIn: www.linkedin.com/company/terra-innovatum-solo.
CONTACTS
Giordano Morichi
Founding Partner, Managing Director of Global Business Development & Investor Relations
Terra Innovatum Corp.
E: g.morichi@terrainnovatum.com
W: www.terrainnovatum.com
Simon Willcocks
Investor and Media Relations
Alliance Advisors IR
E: TerraIR@allianceadvisors.com
IMPORTANT INFORMATION FOR SHAREHOLDERS
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or constitute a solicitation of any vote or approval.
FORWARD LOOKING STATEMENTS
The statements contained in this press release that are not purely historical are forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding our expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on Terra Innovatum. There can be no assurance that future developments affecting Terra Innovatum will be those that we have anticipated. These forward-looking statements speak only as of the date this press release is delivered and involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the ability to recognize the anticipated benefits of the recently-completed Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (2) the risk that the recently-completed Business Combination disrupts current plans and operations of Terra Innovatum, including the expected timetable to achieve its expected commercialization of SOLO; (3) costs related to the completion of the Business Combination, including the costs of compliance with applicable securities laws; (4) changes in applicable laws or regulations; (5) the possibility that Terra Innovatum may be adversely affected by other economic, business, and/or competitive factors; (6) the ability of Terra Innovatum to meet stock exchange listing standards following the consummation of the Business Combination; (7) other risk factors described in the Company’s most recent Annual Report on Form 10-K and other documents subsequently filed with the Securities and Exchange Commission. In addition, there may be additional risks that Terra Innovatum does not presently know or that are currently believed to be immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. Nothing in this communication should be regarded as a representation by any person that the forward- looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made.
Neither Terra Innovatum nor any of its affiliates, officers, employees or agents, makes any representation or warranty, either express or implied, in relation to the fairness, reasonableness, adequacy, accuracy, completeness or reliability of the information, statements or opinions, whichever their source, contained in this press release or any oral information provided in connection herewith, or any data it generates and accept no responsibility, obligation or liability (whether direct or indirect, in contract, tort or otherwise) in relation to any of such information. Terra Innovatum and its affiliates, officers, employees and agents further expressly disclaim any and all liability relating to or resulting from the use of this press release and any errors therein or omissions therefrom.
In addition, the information contained in this press release is provided as of the date hereof and may change, and Terra Innovatum does not undertake any obligation to update or revise any forward- looking statements, whether as a result of new information, inaccuracies, future events or otherwise, except as may be required under applicable securities laws.
